Information for patients
Information for doctors
Information for Researchers
Leaflets, newsletters and posters
Potential therapies
Useful Resources
Participating doctors
Contact Us
Glossary
Publications
Projects supported
Register now
Login

Potential therapies

Drug Development Pipeline for Myotonic Dystrophy Type 1 (DM1) and Myotonic Dystrophy Type 2 (DM2)

The Myotonic Dystrophy Foundation is now tracking the pipeline of potential therapies for Myotonic Dystrophy being developed by pharmaceutical companies. The table includes therapies in early laboratory development all the way up to early and late clinical development.

View the MDF Drug Development Pipeline here